Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Catalina Raymond

Showing results (41-50 of 66) with videos related to

Pageof 7
Sort By:
Journal of Neuro-Oncology|March 11, 2021
Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomasHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Journal of Neuro-Oncology|September 2, 2022
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiationSatoka Shidoh, Ricky R Savjani, Nicholas S Cho, et al.
Neuro-Oncology Advances|April 28, 2026
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumabCollin T Le, Francesco Sanvito, Chuyin Yang, et al.
Scientific Reports|July 23, 2021
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imagingHamed Akbari, Anahita Fathi Kazerooni, Jeffrey B Ware, et al.
Neuro-Oncology|May 9, 2019
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRIJingwen Yao, Ararat Chakhoyan, David A Nathanson, et al.
Journal of Neurosurgery|August 5, 2023
Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastasesFrancesco Sanvito, Donatello Telesca, Nicholas S Cho, et al.
Neuro-Oncology|June 14, 2018
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placeboBenjamin M Ellingson, Lauren E Abrey, Josep Garcia, et al.
Neurosurgery|May 5, 2020
Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor BurdenKunal S Patel, Richard G Everson, Jingwen Yao, et al.
Journal of Neuro-Oncology|June 21, 2025
Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumorsGianluca Nocera, Francesco Sanvito, Jingwen Yao, et al.
Magma (New York, N.Y.)|January 23, 2021
A physical phantom for amine chemical exchange saturation transfer (CEST) MRIJingwen Yao, Chencai Wang, Catalina Raymond, et al.
Pageof 7

Showing results (41-50 of 66) with videos related to

Sort By:
Pageof 7
Journal of Neuro-Oncology|March 11, 2021
Preferential tumor localization in relation to <sup>18</sup>F-FDOPA uptake for lower-grade gliomasHiroyuki Tatekawa, Hiroyuki Uetani, Akifumi Hagiwara, et al.
Journal of Neuro-Oncology|September 2, 2022
Relapse patterns and radiation dose exposure in IDH wild-type glioblastoma at first radiographic recurrence following chemoradiationSatoka Shidoh, Ricky R Savjani, Nicholas S Cho, et al.
Neuro-Oncology Advances|April 28, 2026
Clinical and radiographic prognostic factors in recurrent contrast-enhancing IDH-mutant gliomas treated with bevacizumabCollin T Le, Francesco Sanvito, Chuyin Yang, et al.
Scientific Reports|July 23, 2021
Quantification of tumor microenvironment acidity in glioblastoma using principal component analysis of dynamic susceptibility contrast enhanced MR imagingHamed Akbari, Anahita Fathi Kazerooni, Jeffrey B Ware, et al.
Neuro-Oncology|May 9, 2019
Metabolic characterization of human IDH mutant and wild type gliomas using simultaneous pH- and oxygen-sensitive molecular MRIJingwen Yao, Ararat Chakhoyan, David A Nathanson, et al.
Journal of Neurosurgery|August 5, 2023
Small pretreatment lesion size and high sphericity as favorable prognostic factors after laser interstitial thermal therapy in brain metastasesFrancesco Sanvito, Donatello Telesca, Nicholas S Cho, et al.
Neuro-Oncology|June 14, 2018
Post-chemoradiation volumetric response predicts survival in newly diagnosed glioblastoma treated with radiation, temozolomide, and bevacizumab or placeboBenjamin M Ellingson, Lauren E Abrey, Josep Garcia, et al.
Neurosurgery|May 5, 2020
Diffusion Magnetic Resonance Imaging Phenotypes Predict Overall Survival Benefit From Bevacizumab or Surgery in Recurrent Glioblastoma With Large Tumor BurdenKunal S Patel, Richard G Everson, Jingwen Yao, et al.
Journal of Neuro-Oncology|June 21, 2025
Independent histological validation of MR-derived radio-pathomic maps of tumor cell density using image-guided biopsies in human brain tumorsGianluca Nocera, Francesco Sanvito, Jingwen Yao, et al.
Magma (New York, N.Y.)|January 23, 2021
A physical phantom for amine chemical exchange saturation transfer (CEST) MRIJingwen Yao, Chencai Wang, Catalina Raymond, et al.
Pageof 7